ATE416788T1 - Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme - Google Patents

Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme

Info

Publication number
ATE416788T1
ATE416788T1 AT01944823T AT01944823T ATE416788T1 AT E416788 T1 ATE416788 T1 AT E416788T1 AT 01944823 T AT01944823 T AT 01944823T AT 01944823 T AT01944823 T AT 01944823T AT E416788 T1 ATE416788 T1 AT E416788T1
Authority
AT
Austria
Prior art keywords
oil body
delivery systems
plant oil
vaccine delivery
relates
Prior art date
Application number
AT01944823T
Other languages
English (en)
Inventor
Anthony Schryvers
Wendy Hutchins
Maurice Moloney
Joenel Alcantara
Original Assignee
Sembiosys Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sembiosys Genetics Inc filed Critical Sembiosys Genetics Inc
Application granted granted Critical
Publication of ATE416788T1 publication Critical patent/ATE416788T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01944823T 2000-06-16 2001-06-15 Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme ATE416788T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21213000P 2000-06-16 2000-06-16

Publications (1)

Publication Number Publication Date
ATE416788T1 true ATE416788T1 (de) 2008-12-15

Family

ID=22789675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01944823T ATE416788T1 (de) 2000-06-16 2001-06-15 Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme

Country Status (10)

Country Link
US (2) US20040081654A1 (de)
EP (1) EP1289549B1 (de)
JP (1) JP2004513879A (de)
KR (1) KR20030009538A (de)
AT (1) ATE416788T1 (de)
AU (2) AU6721801A (de)
CA (1) CA2411965A1 (de)
DE (1) DE60136928D1 (de)
MX (1) MXPA02012501A (de)
WO (1) WO2001095934A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
US7601858B2 (en) * 2004-08-17 2009-10-13 Gs Cleantech Corporation Method of processing ethanol byproducts and related subsystems
US9108140B2 (en) 2005-03-16 2015-08-18 Gs Cleantech Corporation Method and systems for washing ethanol production byproducts to improve oil recovery
AU2007217109A1 (en) * 2006-02-16 2007-08-30 Gs Industrial Design, Inc. Method of freeing the bound oil present in whole stillage and thin stillage
WO2007101049A2 (en) * 2006-02-22 2007-09-07 Gs Industrial Design, Inc. Method of converting a fermentation byproduct into oxygen and biomass and related systems
AU2007261445B2 (en) * 2006-06-19 2013-04-18 The Johns Hopkins University Single-molecule PCR on microparticles in water-in-oil emulsions
CN101522213A (zh) 2006-09-01 2009-09-02 Csl有限公司 引起或诱导免疫应答的方法
SG185294A1 (en) 2007-10-12 2012-11-29 Csl Ltd Method of eliciting an immune response against pandemic influenza virus
CA2720755A1 (en) * 2008-04-11 2009-10-15 Sembiosys Genetics, Inc. Controlled release of active agents from oleosomes
CA2748788C (en) * 2009-01-05 2021-02-09 Epitogenesis Inc. The use of a composition comprising mustard oil, catechin, and vitamin a for modulating an immune response
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
WO2011116220A2 (en) * 2010-03-17 2011-09-22 Arbonne International Llc Oral supplement
EP2723378A4 (de) 2011-06-24 2015-01-28 Epitogenesis Inc Pharmazeutische zusammensetzungen mit einer kombination aus ausgewählten trägern, vitaminen, tanninen und flavonoiden als antigenspezifischen immunmodulatoren
JP6253210B1 (ja) 2016-08-17 2017-12-27 一般財団法人日本生物科学研究所 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット
US12133539B2 (en) 2019-03-19 2024-11-05 Conopco, Inc. Frozen confection
CN110179975B (zh) * 2019-06-15 2021-01-08 浙江大学 植物油疫苗佐剂及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
US5948682A (en) * 1991-02-22 1999-09-07 Sembiosys Genetics Inc. Preparation of heterologous proteins on oil bodies
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5484719A (en) * 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5723755A (en) * 1995-05-16 1998-03-03 Francis E. Lefaivre Large scale production of human or animal proteins using plant bioreactors
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US6761914B2 (en) * 1997-05-27 2004-07-13 Sembiosys Genetics Inc. Immunogenic formulations comprising oil bodies
ES2301197T3 (es) * 1997-05-27 2008-06-16 Sembiosys Genetics Inc. Utilizaciones de cuerpos oleosos.

Also Published As

Publication number Publication date
EP1289549A2 (de) 2003-03-12
US20040081654A1 (en) 2004-04-29
DE60136928D1 (de) 2009-01-22
US20060233816A1 (en) 2006-10-19
WO2001095934A3 (en) 2002-08-08
WO2001095934A2 (en) 2001-12-20
JP2004513879A (ja) 2004-05-13
KR20030009538A (ko) 2003-01-29
AU6721801A (en) 2001-12-24
CA2411965A1 (en) 2001-12-20
EP1289549B1 (de) 2008-12-10
MXPA02012501A (es) 2003-06-06
AU2001267218B2 (en) 2006-02-02
AU2001267218C1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
DE60136928D1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
NO20015073D0 (no) Vaksiner
ZA202401922B (en) Coronavirus vaccine formulations
CY1111553T1 (el) Φαρμακοτεχνικες μορφες εμβολιου γριπης για ενδοδερμικη χορηγηση
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
MY126588A (en) Intranasal influenza virus vaccine
DK1404363T3 (da) Adjuvanssammensætning til mucosalt og injektionsfremførte vacciner
AR035586A1 (es) Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
GB2386072A (en) Novel vaccine
WO2023102448A3 (en) Coronavirus vaccine formulations
EP1471936A4 (de) Hiv-vakzine und anwendungsverfahren
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
DK0833903T3 (da) Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus
MY127452A (en) Vaccines.
TW200509964A (en) VP1 of foot-and-mouth disease virus
UA90493C2 (ru) Альфа-тимозиновые пептиды как адьюванты противораковых вакцин
WO2005123112A3 (en) Method of enhancing the immune response to a vaccine
WO2002030458A8 (en) Yersinia adhesion protein as vaccine adjuvant
ITRM20010332A1 (it) Vaccini a subunita' e procedimenti per la loro produzione.
WO2002026254A3 (en) Non-replicative particulate vaccine delivery system and methods of making and using same
ATE305941T1 (de) Impfstoff
RU2004102296A (ru) Способ вакцинопрфилактики взрослых против дифтерии и столбняка на крайнем севере
RU2001103468A (ru) Способ усиления иммунного ответа при вакцинации крупного рогатого скота против бруцеллеза
PH12012501498A1 (en) Vaccine vectors and methods of enhancing immune responses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties